RobertThomasKeenanMDMPH, MBA

Rheumatology • Florence, SC

Crystal Related, Spondyloarthropathy, Vasculitis

Adjunct Associate Professor, Medicine, Duke University School of Medicine

Join to view full profile

Dr. Keenan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Keenan's full profile

Already have an account?

Office
800 E. Cheves St.
Suite 280
Florence, SC 29506
Phone+1 843-973-8770

Fax+1 843-428-2490

Education & Training

University of MassachusettsMBA, 2014 - 2017
NYU Grossman School of MedicineFellowship, Rheumatology, 2007 - 2009
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2004 - 2007
St. George's University School of MedicineClass of 2004
University of North Carolina at Chapel HillMPH, 1998 - 2000

Certifications & Licensure

NC State Medical License 2009 - 2025
SC State Medical License 2020 - 2025
NY State Medical License 2007 - 2009
VA State Medical License 2007 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

4 citations
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
Herbert S B Baraf, Puja P Khanna, Alan J Kivitz, Vibeke Strand, Hyon K Choi
Rheumatology. 2024-04-02
1 citations
Pegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels.
Robert T Keenan, Anthony E Yeo, Peter E Lipsky
Clinical and Experimental Rheumatology. 2022-05-01
4 citations
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.
John K Botson, Herbert S B Baraf, Robert T Keenan, John Albert, Karim R Masri
Current Rheumatology Reports. 2022-01-01

Press Mentions

12 Myths About Gout That You Should Stop Believing NowMay 21st, 2021
Clinician Q&A: Can Immunomodulators Improve the Effect of Pegloticase in Uncontrolled Gout?April 2nd, 2021
What Is a Good Diet for Gout That Will Reduce Your Risk of Painful Flare-UpsFebruary 24th, 2020

Professional Memberships

American College of Rheumatology - ACR
Fellow